SRC and cancer: In vitro studies, such as treating cancer cell lines with small-molecule inhibitors (e.g., SRC inhibitors like dasatinib or trametinib) or inducing mitophagy via PINK1 activators, could further elucidate the therapeutic relevance of these genes in overcoming drug resistance.